Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | Insights from ADVANCE IV study: efgartigimod increases platelet counts of patients with ITP

Catherine Broome • 12 Dec 2022
ASH 2022
Immune Thrombocytopenia Non-Malignant Efgartigimod
Advance IV

Catherine Broome, MD, Georgetown University Hospital, Washington, DC, presents the results of the ADVANCE IV study (NCT01526785) which demonstrated that the neonatal Fc receptor agonist efgartigimod improves platelet counts in patients with immune thrombocytopenia (ITP). This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Dianthus: Consultancy; Alexion: Honoraria, Research Funding; Argenx: Honoraria, Research Funding; Sanofi: Honoraria, Research Funding; Annexon: Research Funding; Novartis: Research Funding; Incyte: Honoraria, Research Funding; Electra: Research Funding.

More from Catherine Broome

1:50
Unmet needs in the treatment and management of cold agglutinin disease
Catherine Broome • 18 Dec 2023
1:30
Targeting the complement cascade in autoimmune hemolytic anemias
Catherine Broome • 18 Dec 2023
1:59
Sutimlimab in cold agglutinin disease: a post-hoc analysis of safety data from CARDINAL & CADENZA
Catherine Broome • 18 Dec 2023
2:50
Time to achieve platelet count response with efgartigimod in patients with persistent/chronic ITP
Catherine Broome • 18 Dec 2023

Related Videos

2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
1:23
Developing a PRO collection tool for patients with SCD: key themes which are important to patients
Nirmish Shah • 8 Dec 2023
The content of VJHemOnc is intended for healthcare professionals